Skip to main content

DiscoveRx to Provide GSK with GPCR Screening Tech

NEW YORK (GenomeWeb News) – DiscoveRx said today that it will provide GlaxoSmithKline with cell lines and reagents for G-protein coupled receptor screening.

Under the worldwide pact, DiscoveRx, based in Fremont, Calif., will provide GSK with access to its PathHunter beta-arresting parental cell lines, clones, and associated reagents for use in GSK's internal GPCR screening and profiling efforts.

Financial terms of the agreement were not disclosed.

DiscoveRx said that the agreement follows in the wake of a collaborative GPCR orphan receptor program that included GSK, DiscoveRx, and the UK's Medical Research Council.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.